2001, Clinical Research and Trials - Drug Discovery Digest

2001

Clinical Research

Trials

Four Pain Models Altasciences Uses to Assess Treatments During Clinical Trials

Alta Sciences

SEPTEMBER 13, 2023

Four Pain Models Altasciences Uses to Assess Treatments During Clinical Trials pmjackson Wed, 09/13/2023 - 17:01 September is pain awareness month, and the importance of pain management and continued research into effective analgesics is integral to helping patients suffering from various pain conditions.

Clinical Trials

Clinical Trials Treatment Trials Drug Development

Keys to Success in Vaccine Development for Special Populations

PPD

MAY 11, 2023

To effectively implement vaccine clinical trials for special populations, it is critical for vaccine developers to partner with a contract research organization (CRO) that has demonstrated experience recruiting and retaining pediatric and elderly study participants — and managing the nuances these patients and their caregivers require.

Vaccine

Vaccine Clinical Trials Long-Term Care Facilities Trials

Join 15,000+

Insiders

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

Where is the drug discovery expertise happening in the UK?

Drug Discovery World

OCTOBER 16, 2023

CellProthera selected the UK centres for their excellence in the conduct of clinical research with dedicated staff, equipment, availability of imaging platforms and high interest in cell therapy cardiovascular trials especially University Hospital of Birmingham equipped with a bi-plane Cathlab.

Drugs

Drugs Science Therapies Targeted Protein Degradation

Article FDA Thank You The FDA rejected a psychedelic sponsor’s bid for approval. Here are six industry takeaways

Agency IQ

AUGUST 16, 2024

FDA released a draft guidance in June 2023 attempting to address many of these unique aspects of clinical research on psychedelic substances. As AgencyIQ discussed in-depth at the time , the committee grappled with data flaws and gaps within the context of positive trials and high unmet need.

FDA

FDA Trials Regulations Therapies

Chipscreen and HISUN reach a strategic cooperation

The Pharma Data

DECEMBER 15, 2020

As the world’s first PPAR pan agonist that completed two confirmatory phase III clinical trials, Chiglitazar Sodium has shown significant and long-lasting hypoglycemic effects in a series of clinical studies, as well as other comprehensive effects including significant insulin sensitization and blood lipid regulation.

Pharmaceuticals

Pharmaceuticals Small Molecule Clinical Trials Production

Navigating the Complex Regulatory CRO Landscape for Oncology Trials in the European Union

Conversations in Drug Development Trends

MAY 23, 2024

By: Sarah Bly, Regulatory Science and Innovation and Matt Cooper, Executive Director, Therapeutic Strategy Lead, Oncology The European Union (EU) presents a unique set of regulatory challenges and opportunities for clinical trials in oncology. Increased Transparency : Ensures that information on clinical trials is more accessible.

Trials

Trials Clinical Trials Therapies Regulations

Where is the promise for plant-based medicines? Part 2: Psilocybin

Drug Discovery World

AUGUST 24, 2023

Dr Samuel Weiss, Scientific Director of the Canadian Institutes of Health Research Institute of Neurosciences, Mental Health and Addiction, says: “We are beginning to see a resurgence of research on psychedelics as a potential therapeutic aid for a range of mental health and substance use conditions. One such focus is psilocybin.

Clinical Trials

Clinical Trials Treatment Regulations Trials

Pivotal phase III clinical trial IND submission of the original innovative anticancer drug Chiauranib for the treatment of small cell lung cancer was accepted by the Center of Drug Evaluation of the NMPA.

The Pharma Data

JANUARY 10, 2021

SH ) submitted its pivotal phase III clinical trial application (IND) of national class I innovative drug Chiauranib to NMPA, for the treatment of Small Cell Lung Cancer (SCLC) as a single agent for the patients after 2nd-line systemic chemotherapy and recurrence afterwards. SHENZHEN, China , Jan. About CHIPSCREEN BIOSCIENCES.

Clinical Trials

Clinical Trials Treatment Trials Small Molecule

Human neuronal cells: possibilities in drug safety testing

Drug Target Review

SEPTEMBER 26, 2023

She completed a PhD at Durham University which focused on investigating the mechanisms of cardiotoxicity of cancer therapies using clinically relevant in vitro human models of cardiac physiology paired with novel methodologies to evaluate structural and functional toxicities. 2001 Sep;24(9):517–26. Adv Drug Deliv Rev. Trends Neurosci.

Drugs

Drugs FDA Disease Animal Testing

New horizon for cancer innovation

Drug Discovery World

OCTOBER 7, 2022

This funding is distributed between funding discovery research at our core institutes, and at universities around the UK, clinical research, cancer grand challenges, and translational research. . Recent studies have shown that academic inventors contributed 37% of cancer medicines between 2001-2019.

Pharma Companies

Pharma Companies Science Research Drug Development

Article FDA Thank You FDA updates set the stage for broader use of harmonized standards for safety reporting

Agency IQ

APRIL 8, 2024

In 2012, the passage of the FDA Safety and Innovation Act (FDASIA) created a new requirement for sponsors to submit all drug submissions, including clinical trial applications, in an electronic format as specified by FDA guidance. This was an area that FDA investigators recently interviewed by the U.S.

FDA

FDA Production Regulations Vaccine

Raising Welfare for Lab Rodents

Codon

JULY 21, 2024

In an effort to continue this cycle, researchers at UBC also try to get their animals adopted at the end of their studies. According to Weary, the “recognition that the animal is an individual that has a life beyond this particular trial” positively influences their treatment at the hands of researchers.

Research

Research Engineering Science Disease

Let's Quit Sugar With Audiobook – Let's Quit Sugar

The Pharma Data

MAY 13, 2021

2001 Nov 16;12(16):3549-52. based weight loss intervention in adults with obesity: A randomized clinical trial. Clinical Research Strategies for Fructose Metabolism. 2001 Sep;30(3):765-85. Colantuoni C, Schwenker J, McCarthy J, Rada P, Ladenheim B, Cadet JL, Schwartz GJ, Moran TH, Hoebel BG. Neuroreport.

Disease

Disease Production Testimonials Science

How the Fifty States View Electronic Data as a “Product”

Drug & Device Law

JULY 31, 2023

2001); Isham v. 2001), relied on these other statutes to hold that a road could not be a “product”). mentioned with approval an unappealed trial court ruling that, as to “strict liability,” a cellphone “app was not a product, and thus a products liability theory of recovery was not legally viable.” Huntington Ingalls Inc. ,

Production

Production International Trials Government

Four Pain Models Altasciences Uses to Assess Treatments During Clinical Trials

Keys to Success in Vaccine Development for Special Populations

Trending Sources

Where is the drug discovery expertise happening in the UK?

Article FDA Thank You The FDA rejected a psychedelic sponsor’s bid for approval. Here are six industry takeaways

Chipscreen and HISUN reach a strategic cooperation

Navigating the Complex Regulatory CRO Landscape for Oncology Trials in the European Union

Where is the promise for plant-based medicines? Part 2: Psilocybin

Pivotal phase III clinical trial IND submission of the original innovative anticancer drug Chiauranib for the treatment of small cell lung cancer was accepted by the Center of Drug Evaluation of the NMPA.

Human neuronal cells: possibilities in drug safety testing

New horizon for cancer innovation

Article FDA Thank You FDA updates set the stage for broader use of harmonized standards for safety reporting

Raising Welfare for Lab Rodents

Let's Quit Sugar With Audiobook – Let's Quit Sugar

How the Fifty States View Electronic Data as a “Product”

Stay Connected